Status Report: Getting Hyper About Ritalin

An FDA advisory panel last week recommended adding the agency's strongest possible safety warning for Ritalin and other popular attention-deficit drugs. Here's what's behind the buzz:

Is the proposal based on new data? No. The panel had been tasked with suggesting studies to explore the cardiovascular effects of these drugs. The idea of adding a "black box" warning came as a surprise.

Do these drugs pose a risk to the heart? Maybe. Ritalin and its cousins Concerta and Adderall are stimulants that can raise heart rate and blood pressure. The FDA knows of 25 cases of people--19 of them children--dying suddenly...

Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!